Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Klinisk utveckling av Orphan Drug ´anti-pseudomonas IgY´ för patienter med Cystisk Fibrosis

Reference number
Coordinator Immun System I.M.S. Aktiebolag
Funding from Vinnova SEK 25 000
Project duration July 2010 - December 2010
Status Completed

Last updated 25 November 2019

Reference number 2010-01727

Page statistics